Work

Coste-efectividad de dasatinib frente a dosis altas de imatinib y nilotinib en pacientes con leucemia mieloide crónica resistente a la dosis estándar de imatinib en Portugal

Year: 2013

Type: article

Source: PharmacoEconomics Spanish Research Articles

DOI: 10.1007/s40277-013-0027-2

Authors: Josep Darbà, Lisette Kaskens, Manuel Abecassis, Joao Carrasco, Ricardo Vitorino, Matthew Taylor

Institutions: Universitat de Barcelona, Instituto Português de Oncologia Francisco Gentil, Bristol-Myers Squibb (Portugal), University of York

Language: Spanish

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2000253072

FWCI:

Cites: 32

Cited by:

Related to: 10